Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 312

Results For "bio"

3865 News Found

GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech
Medical Device | May 12, 2022

GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech

GenNext and Kiko Tech will provide sales and marketing, customer service, technical support, training, and related logistical efforts for Flash Oxidation Protein Footprinting Systems.


OvaCis rapid test to detect ovarian cancer gets CE mark
Drug Approval | May 12, 2022

OvaCis rapid test to detect ovarian cancer gets CE mark

Revolutionary ovarian cancer rapid test available Q4 2022


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


New nirsevimab data analyses reinforce efficacy against RSV
Biotech | May 11, 2022

New nirsevimab data analyses reinforce efficacy against RSV

Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose


Novo Nordisk and Flagship Pioneering partner to create a portfolio of transformational medicines
Biotech | May 10, 2022

Novo Nordisk and Flagship Pioneering partner to create a portfolio of transformational medicines

Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases


Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY
News | May 10, 2022

Aarti Drugs Q4FY 22 consolidated revenue grew by 39 per cent YoY

The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt


Indian Pharma Market slips for third month in a row: Anand Rathi
News | May 10, 2022

Indian Pharma Market slips for third month in a row: Anand Rathi

According to the brokerage, as the pandemic has receded, the past exceptional growth in acute therapies may not be repeated (stellar double-digit growth for anti-infectives coming down)


Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
News | May 09, 2022

Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA

Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets


InxMed raises US $ 15 million in Series B+ financing
Startup | May 09, 2022

InxMed raises US $ 15 million in Series B+ financing

The plan is to advance innovative therapies to drug-resistant cancers


SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
Biotech | May 09, 2022

SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer

SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer